Atypical haemolytic uraemic syndrome (aHUS) - eculizumab extended initial PBS authority application Supporting information form (PB175)
Use this form for a patient applying for extended initial treatment with Pharmaceutical Benefit Scheme (PBS) subsidised eculizumab for aHUS.
This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.
If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.
Page last updated: 20 February 2020
This information was printed 4 January 2021 from https://www.servicesaustralia.gov.au/organisations/health-professionals/forms/pb175. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/individuals/site-notices when using this material.